STAT

FEBRUARY 15, 2024

The Department of Health and Human Services announced Thursday that it is filling eight vacancies, including the chairmanship, on an important advisory panel on vaccine policy that was down to less than half of its normal roster for months.

Vaccines 353

Vaccines Immunization Immunity 353

STAT

MAY 17, 2024

HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few months ago, the last trial expected to potentially deliver a vaccine within this decade was shut down.

Vaccines 357

Vaccines Immunity Immunization 357

STAT

NOVEMBER 10, 2023

An expert panel that advises the United Kingdom on vaccine policy has recommended using a meningitis B vaccine to try to bring down spiking rates of gonorrhea. would be the first country to use the meningitis B vaccine for this purpose. If adopted, the U.K.

Vaccines 363

Vaccines Immunization Immunity 363

STAT

NOVEMBER 8, 2023

Vaccines work well to prevent cancers caused by the human papillomavirus (HPV). So well, in fact, that it may be time to review HPV screening protocols, according to the somewhat provocative conclusion of a new study examining the occurrence of genital HPV types eight years after immunization, published today in Cell Host & Microbe.

Vaccines 364

Vaccines Immunity Immunization 364

STAT

MAY 5, 2023

A new study sheds light on what may be causing very rare cases of heart inflammation in young men after receiving an mRNA Covid vaccine. But the study , published Friday in Science Immunology, doesn’t find evidence for any of these mechanisms.

Vaccines 364

Vaccines Immunization Immunity 364

STAT

JUNE 26, 2024

Makers of RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday, when an expert committee that advises the Centers for Disease Control and Prevention on vaccines recommended changes that will likely see fewer older adults qualify for insurance coverage for these products.

Vaccines 330

Vaccines Immunity Immunization 330

STAT

APRIL 10, 2024

SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. The promise has long been an affordable, personalized cancer vaccine that could train the immune system to recognize proteins from cancer cells and, subsequently, destroy the tumor.

Vaccines 364

Vaccines Immunity Immunization Drug Development 364

STAT

FEBRUARY 29, 2024

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest. Read the rest…

Vaccines 358

Vaccines Immunization Immunity 358

STAT

OCTOBER 2, 2023

Last month, the first volunteer was injected with an HIV vaccine he spent over 20 years designing.   Truthfully, though, Picker isn’t sure his HIV vaccine stands much of a chance.   Truthfully, though, Picker isn’t sure his HIV vaccine stands much of a chance. It’s prototype No.

Vaccines 355

Vaccines Immunization Immunity 355

STAT

FEBRUARY 8, 2024

vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country. The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year.

Vaccines 363

Vaccines Immunity Immunization 363

STAT

AUGUST 21, 2023

The Food and Drug Administration on Monday approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter part of pregnancy. The vaccine, Abrysvo, has also been approved for use in adults 60 and older to protect them against respiratory syncytial virus. Read the rest…

Vaccines 246

Vaccines Immunity Immunization 246

STAT

NOVEMBER 4, 2022

New data from Pfizer and BioNTech on their bivalent Covid-19 vaccine suggests the updated product may be more protective against more recent Omicron subvariants than the original version of the vaccine, the companies said in a statement released Friday. The companies said the levels of neutralizing antibodies that target the BA.4

Vaccines 349

Vaccines Immunity Immunization 349

STAT

OCTOBER 2, 2023

and Europe are ramping up their campaigns urging eligible people to get another vaccine round against Covid and flu, promoting the immunizations as people’s best way to protect themselves and reduce pressure on health systems during what is expected to be another tough winter. LONDON — Health officials in the U.K.

Vaccines 317

Vaccines Immunization Immunity 317

STAT

MARCH 28, 2023

A panel of experts that advises the World Health Organization on vaccine use suggested Tuesday that countries no longer need to consider offering additional Covid-19 boosters to people at medium or low risk of becoming seriously ill if they contract the SARS-CoV-2 virus.

Vaccines 330

Vaccines Immunization Immunity 330

STAT

FEBRUARY 29, 2024

Flu vaccine appears to be offering reasonable levels of protection this winter, with particularly strong levels in children, new data from the Centers for Disease Control and Prevention suggest. Read the rest…

Vaccines 289

Vaccines Immunization Immunity 289

STAT

MAY 18, 2023

A committee of vaccine experts voted to recommend the Food and Drug Administration approve Pfizer’s maternal RSV vaccine on Thursday, though the panel expressed some safety concerns. Read the rest…

Vaccines 266

Vaccines Immunization Immunity 266

STAT

JUNE 7, 2023

LONDON — The European Commission approved GSK’s RSV vaccine, the company said Wednesday, bringing to the market the first such tool that can protect older adults from the common respiratory bug.     The vaccine, Arexvy, was authorized for adults 60 and older. Arexvy won U.S. Read the rest…

Vaccines 246

Vaccines Immunization Immunity 246

STAT

APRIL 19, 2023

An expert panel that advises the Centers for Disease Control and Prevention on vaccination policy informally endorsed a plan Wednesday to offer an additional Covid-19 booster shot to people 65 and older as well as people who are immunocompromised, and to simplify the Covid vaccine schedule.

Vaccines 266

Vaccines Immunization Immunity 266

STAT

JULY 17, 2023

Global childhood immunization coverage has nearly rebounded to pre-pandemic levels, according to a new report, with 4 million more children receiving full immunization in 2022 compared to 2021. But the report, released Monday by UNICEF and the World Health Organization (WHO), also shows that recovery is lagging in low-income countries.

Vaccines 246

Vaccines Immunization Immunity 246

STAT

JUNE 21, 2023

A panel of experts  that advises the Centers for Disease Control and Prevention on vaccinations opted Wednesday not to recommend that all seniors get a vaccine to protect against RSV.

Vaccines 246

Vaccines Immunization Immunity 246

STAT

NOVEMBER 2, 2022

Immunizations shipped to doorsteps around the globe is the dream of Michael Schrader, chief executive and cofounder of Vaxess. In the future, getting a flu shot might be as easy as opening the mailbox and slapping a skin patch on your arm. For more than a decade, the Cambridge, Mass., For more than a decade, the Cambridge, Mass.,

Vaccines 253

Vaccines Immunization Immunity 253

STAT

FEBRUARY 28, 2024

In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH.

Vaccines 289

Vaccines Diabetes Immunity Immunization 289

STAT

MARCH 3, 2023

The HPV vaccine is a slam dunk in preventing the vast majority of cancers related to the infection — namely tumors of the head and neck , anus, penis, vagina, and cervix. Everyone else must hope for other vaccines that scientists are developing to treat existing HPV-associated cancer.

Vaccines 253

Vaccines Immunity Immunization 253

STAT

OCTOBER 17, 2022

… Vaccines that target cancer could be available before the end of the decade, according to the husband and wife team behind one of the most successful Covid vaccines , the BBC tells us. Continue to STAT+ to read the full story…

Vaccines 253

Vaccines Immunity Immunization 253

European Pharmaceutical Review

MARCH 6, 2023

The first clinical trial of any subunit tuberculosis (TB) vaccine in a temperature-stable form has found that ID93+GLA-SE, a freeze-dried vaccine, was safe. The recombinant subunit vaccine is made from four proteins of Mycobacterium tuberculosis bacteria combined with GLA-SE, an immune-stimulating adjuvant.

Immunity 103

Immunity Immunization Vaccines Communication 103

European Pharmaceutical Review

JUNE 13, 2023

If approved, VLA1553 could become the first licensed chikungunya vaccine” A single vaccination of VLA1553 has been shown to produce neutralising antibody levels, thought to protect against chikungunya disease in 99 percent of Phase III trial participants. What did the chikungunya vaccine study results show?

Immunity 105

Immunity Immunization Vaccines 105

STAT

NOVEMBER 3, 2022

… A Delaware federal court refused to throw out patent infringement claims brought by Arbutus Biopharma and Genevant Sciences against Moderna over its sale of Covid-19 vaccine doses to the U.S.  Genevant and Arbutus sued Moderna in February, seeking royalties from Moderna’s sale of its Covid-19 vaccine.

Vaccines 244

Vaccines Immunity Immunization 244

pharmaphorum

SEPTEMBER 7, 2020

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. The vaccine also produced a T-cell response within 28 days, a secondary outcome.

Immunity 107

Immunity Immunization Vaccines Hospitals 107

Express Pharma

JUNE 20, 2023

The vaccine efforts of the COVID-19 pandemic highlighted our knowledge about gaps in the immune system. Reductionist systems, such as genetically identical inbred mice, have long been the choice for immunology research, which focuses on studying the cells, tissues, and organs that make up the immune system.

Immunity 105

Immunity Immunization Vaccines Hospitals 105

NY Times

JULY 4, 2021

France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.

Immunity 89

Immunity Immunization Vaccines 89

World Pharma News

OCTOBER 10, 2023

A University of Massachusetts Amherst team has demonstrated in theory that a protein antigen from a childhood vaccine can be delivered into the cells of a malignant tumor to refocus the body’s immune system against the cancer, effectively halting it and preventing its recurrence.

Immunity 95

Immunity Immunization Vaccines 95

Pharma Times

DECEMBER 2, 2021

Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT).

Vaccines 137

Vaccines Immunity Immunization 137

pharmaphorum

MAY 19, 2022

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt. There are hopes that its mRNA approach, which proved so effective against COVID-19, could succeed where traditional vaccine technologies have failed in HIV.

Vaccines 145

Vaccines Immunity Immunization 145

Pharma Times

JULY 7, 2023

Second dose of treatment generates response among young people during Oxford University trial - News - PharmaTimes

Immunity 130

Immunity Immunization Vaccines 130

World Pharma News

MAY 10, 2024

Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer. They have discovered that a vaccine adjuvant - or "booster" - called C100 promotes potent anti-tumour immunity when it is injected directly into tumours in an animal model.

Immunity 84

Immunity Immunization Vaccines 84

Pharma Times

JUNE 29, 2021

Mixing different vaccines produces a strong immune response against virus, according to researchers

Vaccines 130

Vaccines Immunity Immunization 130

Pharma Times

DECEMBER 7, 2021

Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.

Vaccines 130

Vaccines Immunity Immunization 130